Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis

European Radiology

Volumn 13, Issue 7, 2003, Pages 1685-1692

  Martí Bonmatí, Luis ^a   Fog, Amura F ^b   de Beeck, Bart Op ^c   Kane, Pauline ^d   Fagertun, Hans ^e  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b Amersham Health   (Norway)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Cirrhosis; Contrast agents; Efficacy studies; Liver; Mangafodipir trisodium; MR imaging

Indexed keywords

CONTRAST MEDIUM; MANGAFODIPIR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHENIA; BACKACHE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FLUSHING; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEAT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALAISE; MALE; META ANALYSIS; MUSCLE STIFFNESS; NAUSEA; NECK PAIN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RASH; RETROSPECTIVE STUDY; SIDE EFFECT; SWEATING; TACHYCARDIA; TASTE DISORDER; THIRST; URTICARIA; VERTIGO; VOMITING; XEROSTOMIA;

CONTRAST MEDIA; EDETIC ACID; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; PYRIDOXAL PHOSPHATE; RETROSPECTIVE STUDIES; SAFETY;

EID: 0038267057     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1784-5     Document Type: Article

References (14)

1. Elizondo G, Fretz CJ, Stark DD et al. (1991) Preclinical evaluation of Mangafodipir trisodium: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178:73-78
2. Wang C, Gordon PB, Hustvedt SO et al. (1997) MR imaging properties and pharmacokinetics of Mangafodipir trisodium in healthy volunteers. Acta Radiol 38:665-676
3. Hamm B, Vogl TJ, Branding G, Schnell B, Taupitz M, Wolf KJ, Lissner J (1992) Focal liver lesions: MR imaging with Mn-DPDP initial clinical results in 40 patients. Radiology 182:167-174
4. Murakami T, Baron RL, Federle MP et al. (1996) Cirrhosis of the liver: MR imaging with Mangafodipir trisodium (Mn-DPDP). Radiology 198:567-572
5. Marti-Bonmati L, Lonjedo E, Poyatos C, Casillas C (1998) MnDDP enhancement characteristics and differentiation between cirrhotic and non-cirrhotic livers. Invest Radiol 33:717-722
6. Marchal GM, Ni Y, Yu J, Lodemann KP, Baert AL (1993) Mn-DPDP enhanced MRI in experimental bile duct obstruction. J Comput Assist Tomogr 17:290-296
7. Bernardino ME, Young SW, Lee JK, Weinreb JC (1992) Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 183:53-58
8. Torres CG, Lundby B, Tufte Sterud A, McGill S, Gordon PB, Strand Bjerknes H (1997) Mangafodipir trisodium for MR imaging of the liver. Results from the European phase III studies. Acta Radiol 38:631-637
9. Bartolozzi C, Donati F, Cioni L, Crocetti L, Lencioni R (2000) Mangafodipir trisodium-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 10:1697-1702
10. Gresti A (1990) Categorical data analysis. Wiley, New York
11. Murakami T, Baron RL, Peterson MS, Oliver JH, Davis PL, Confer SR, Federle MP (1996) Hepatocellular carcinoma: MR imaging with Mangafodipir trisodium (Mn-DPDP). Radiology 200:69-77
12. Federle MP, Chezmar JL, Rubin DL et al. (2000) Safety and efficacy of Mangafodipir trisodium injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). J Magn Reson Imaging 12:186-197
13. Marti-Bonmati L, Torregrosa A, Miguel A, Molla E, Dosda R, Arana E (2001) Safety and efficacy of a bolus administration of Mangafodipir trisodium in MR liver studies. Ninth Scientific Meeting ISMRM and 14th Annual meeting ESMRMB
14. Helmberger TK, Laubenberger J, Rummeny E, Jung G, Sievers K, Dohring W, Meurer K, Reiser MF (2002) MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol 12:62-70